Glass Health Programs Inc

About Glass Health Programs Inc

Glass Health Programs Inc is an outpatient opioid treatment program in Baltimore, Maryland, connected to the MedMark Treatment Centers network, which focuses solely on opioid use disorder. They pair FDA-approved medications, methadone and buprenorphine, including the buprenorphine-naloxone combination Suboxone, with counseling to ease withdrawal, curb cravings, and lower the risk of relapse and overdose. Care covers both prescription and illicit opioids, including fentanyl, heroin, oxycodone, hydrocodone, morphine, and tramadol. Because treatment is outpatient, adults 18 and older can keep working, attending school, or caring for family while they recover.

Treatment moves through three phases: an induction phase with a medical assessment, drug screen, and first supervised dose, a stabilization phase where the dose is fine-tuned, and a maintenance phase centered on relapse prevention and long-term stability. Individual counseling is required, usually weekly, and addresses triggers, coping skills, trauma, and repairing relationships, while group and family sessions add peer accountability and help loved ones set healthy boundaries. Support services include case management, coordinated pregnancy care, health monitoring, discharge planning, referrals for housing, employment, and transportation, and guest dosing for patients who travel. The network’s programs are federally certified, state licensed, and CARF-accredited, and they accept most private insurance, Medicare, and Medicaid, with veterans eligible through the VA Community Care Network with prior authorization.